mRNA markers associated with malignant pleural effusion

• Published in: Scientific reports 2023-04, Vol.13 (1), p.6677-6677, Article 6677
• Main Authors: Hsu, Shih-Chang, Chang, Shan-Yueh, Hwang, Yi-Ting, Terng, Harn-Jing, Tsai, Chen-Liang, Shen, Chih-Hao, Huang, Shau Ku, Chian, Chih‑Feng
• Format: Article
• Language: English
• Subjects: 692/308; 692/53; 692/699; Biomarkers, Tumor - metabolism; Biopsy; Carcinoma, Non-Small-Cell Lung - pathology; Cytology; DNA-directed DNA polymerase; Genes; Humanities and Social Sciences; Humans; Lung cancer; Lung Neoplasms - pathology; MDM2 protein; mRNA; multidisciplinary; Neurofibromin 1; Non-small cell lung carcinoma; Nuclear Proteins; Pleural effusion; Pleural Effusion - pathology; Pleural Effusion, Malignant - diagnosis; Pleural fluid; RING finger proteins; ROC Curve; Science; Science (multidisciplinary); Small cell lung carcinoma; Transcription Factors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-32872-2

Malignant pleural effusions (MPE) commonly result from malignant tumors and represent advanced-stage cancers. Thus, in clinical practice, early recognition of MPE is valuable. However, the current diagnosis of MPE is based on pleural fluid cytology or histologic analysis of pleural biopsies with a low diagnostic rate. This research aimed to assess the diagnostic ability of eight previously identified Non-Small Cell Lung Cancer (NSCLC)-associated genes for MPE. In the study, eighty-two individuals with pleural effusion were recruited. There were thirty-three patients with MPE and forty-nine patients with benign transudate. mRNA was isolated from the pleural effusion and amplified by Quantitative real-time PCR. The logistic models were further applied to evaluate the diagnostic performance of those genes. Four significant MPE-associated genes were discovered in our study, including Dual-specificity phosphatase 6 (DUSP6), MDM2 proto-oncogene (MDM2), Ring finger protein 4 (RNF4), and WEE1 G2 Checkpoint Kinase (WEE1). Pleural effusion with higher expression levels of MDM2 and WEE1 and lower expression levels of RNF4 and DUSP6 had a higher possibility of being MPE. The four-gene model had an excellent performance distinguishing MPE and benign pleural effusion, especially for pathologically negative effusions. Therefore, the gene combination is a suitable candidate for MPE screening in patients with pleural effusion. We also identified three survival-associated genes, WEE1, Neurofibromin 1 (NF1), and DNA polymerase delta interacting protein 2 (POLDIP2), which could predict the overall survival of patients with MPE.